Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma

Abstract Background Immune checkpoint inhibitors have improved clinical outcomes including survival in several malignancies but have also been associated with a range of immune-related adverse events (irAEs). Neurological irAEs are rare compared to the more typical skin, gastrointestinal, and endocr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Catherine A. Gao, Urs M. Weber, Aldo J. Peixoto, Sarah A. Weiss
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2019-10-01
Serija:Journal for ImmunoTherapy of Cancer
Teme:
Immune checkpoint inhibitors
Ipilimumab
Nivolumab
Autoimmune
Autonomic ganglionopathy
Melanoma
Online dostop:http://link.springer.com/article/10.1186/s40425-019-0748-0
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki